2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
187
Thoracic
13
NET
10
Endocrine
10
Sarcoma
9
Head & Neck
9
Breast
9
Gynecologic
8
Genitourinary
8
Dermatologic
5
Lymphoid
4
CNS
3
Classical hematology
2
Plasma cell
1
Other neoplasm
1
Other hematologic neoplasm
1
Myeloid
1
Conditions
Multiple Myeloma
3568
Neoplasms, Plasma Cell
696
Lymphoma
531
Lymphoma, Non-Hodgkin
480
Leukemia, Lymphocytic, Chronic, B-Cell
409
Hodgkin Disease
405
Recurrence
401
Precursor Cell Lymphoblastic Leukemia-Lymphoma
375
Leukemia
373
Leukemia, Myeloid, Acute
363
Myelodysplastic Syndromes
331
Lymphoma, Large B-Cell, Diffuse
290
Lymphoma, Mantle-Cell
288
Lymphoma, Follicular
284
Lymphoma, B-Cell, Marginal Zone
256
Burkitt Lymphoma
249
Myeloproliferative Disorders
226
Immunoglobulin Light-chain Amyloidosis
224
Lymphoma, Large-Cell, Immunoblastic
223
Neoplasms
213
Hematologic Neoplasms
200
Primary Myelofibrosis
186
Leukemia, Myeloid, Chronic-Phase
182
Leukemia, Myeloid, Accelerated Phase
173
Lymphoma, T-Cell, Cutaneous
170
Waldenstrom Macroglobulinemia
164
Blast Crisis
162
Leukemia, Myelomonocytic, Chronic
158
Mycosis Fungoides
147
Sezary Syndrome
146
Interventions
Tinzaparin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Digestive System Neoplasms
×
Plasma cell
×
Clear all
NCT03099031
2019-12-16
PREDICARE
LEO Pharma
Completed
420 enrolled